These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 15480820)

  • 1. Successful use of ketamine for intractable cancer pain.
    Lossignol DA; Obiols-Portis M; Body JJ
    Support Care Cancer; 2005 Mar; 13(3):188-93. PubMed ID: 15480820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents.
    Finkel JC; Pestieau SR; Quezado ZM
    J Pain; 2007 Jun; 8(6):515-21. PubMed ID: 17434801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a randomized, controlled, double-blind, crossover, double-dose study.
    Mercadante S; Arcuri E; Tirelli W; Casuccio A
    J Pain Symptom Manage; 2000 Oct; 20(4):246-52. PubMed ID: 11027905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low doses of epidural ketamine or neostigmine, but not midazolam, improve morphine analgesia in epidural terminal cancer pain therapy.
    Lauretti GR; Gomes JM; Reis MP; Pereira NL
    J Clin Anesth; 1999 Dec; 11(8):663-8. PubMed ID: 10680109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose subcutaneous ketamine infusion and morphine tolerance.
    Bell RF
    Pain; 1999 Oct; 83(1):101-3. PubMed ID: 10506678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized, double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain.
    Hardy J; Quinn S; Fazekas B; Plummer J; Eckermann S; Agar M; Spruyt O; Rowett D; Currow DC
    J Clin Oncol; 2012 Oct; 30(29):3611-7. PubMed ID: 22965960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ketamine spares morphine consumption after transthoracic lung and heart surgery without adverse hemodynamic effects.
    Nesher N; Serovian I; Marouani N; Chazan S; Weinbroum AA
    Pharmacol Res; 2008 Jul; 58(1):38-44. PubMed ID: 18602474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ketamine and N-acetylaspartylglutamate peptidase inhibitor exert analgesia in bone cancer pain.
    Saito O; Aoe T; Kozikowski A; Sarva J; Neale JH; Yamamoto T
    Can J Anaesth; 2006 Sep; 53(9):891-8. PubMed ID: 16960267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Dose Ketamine Infusion for Emergency Department Patients with Severe Pain.
    Ahern TL; Herring AA; Miller S; Frazee BW
    Pain Med; 2015 Jul; 16(7):1402-9. PubMed ID: 25643741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Case report: efficacy and tolerability of ketamine in opioid-refractory cancer pain.
    Amin P; Roeland E; Atayee R
    J Pain Palliat Care Pharmacother; 2014 Sep; 28(3):233-42. PubMed ID: 25102039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-emptive analgesia with ketamine, morphine and epidural lidocaine prior to total knee replacement.
    Wong CS; Lu CC; Cherng CH; Ho ST
    Can J Anaesth; 1997 Jan; 44(1):31-7. PubMed ID: 8988821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution to variability in response to opioids.
    Hanks GW; Reid C
    Support Care Cancer; 2005 Mar; 13(3):145-52. PubMed ID: 15761703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of continuous intravenous ketamine for end-stage cancer pain in children.
    Conway M; White N; Jean CS; Zempsky WT; Steven K
    J Pediatr Oncol Nurs; 2009; 26(2):100-6. PubMed ID: 19202116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care.
    Salas S; Frasca M; Planchet-Barraud B; Burucoa B; Pascal M; Lapiana JM; Hermet R; Castany C; Ravallec F; Loundou A; Auquier P; Duffaud F; Baumstarck K
    J Palliat Med; 2012 Mar; 15(3):287-93. PubMed ID: 22335487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness and adverse effects profile of "burst" ketamine in refractory cancer pain: The VCOG PM 1-00 study.
    Jackson K; Ashby M; Howell D; Petersen J; Brumley D; Good P; Pisasale M; Wein S; Woodruff R
    J Palliat Care; 2010; 26(3):176-83. PubMed ID: 21047040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Burst" ketamine for refractory cancer pain: an open-label audit of 39 patients.
    Jackson K; Ashby M; Martin P; Pisasale M; Brumley D; Hayes B
    J Pain Symptom Manage; 2001 Oct; 22(4):834-42. PubMed ID: 11576800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketamine subcutaneous continuous infusion for non-cancer neuropathic pain at home: a case report.
    Julião M; Ulrich J; Calaveiras P; Costa E; Lucas I; Faria de Sousa P
    BMJ Support Palliat Care; 2024 Jan; 13(e3):e902-e907. PubMed ID: 37433626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term treatment with ketamine in a 12-year-old girl with severe neuropathic pain caused by a cervical spinal tumor.
    Klepstad P; Borchgrevink P; Hval B; Flaat S; Kaasa S
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):616-9. PubMed ID: 11902308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketamine combined with morphine for the management of cancer pain in a patient with meperidine tolerance and addiction.
    Akin Takmaz S; Inan N; Günal S; Kaymak C; Sakalli M; Dikmen B
    Agri; 2005 Jul; 17(3):44-7. PubMed ID: 16158342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.